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Abstract The development of highly efficient analytical
methods capable of probing biological systems at system
level is an important task that is required in order to meet
the requirements of the emerging field of systems biology.
Optical molecular imaging (OMI) is a very powerful tool
for studying the temporal and spatial dynamics of specific
biomolecules and their interactions in real time in vivo. In
this article, recent advances in OMI are reviewed
extensively, such as the development of molecular probes
that make imaging brighter, more stable and more
informative (e.g., FPs and semiconductor nanocrystals,
also referred to as quantum dots), the development of
imaging approaches that provide higher resolution and
greater tissue penetration, and applications for measuring
biological events from molecule to organism level,
including gene expression, protein and subcellular com-
partment localization, protein activation and interaction,
and low-mass molecule dynamics. These advances are of
great significance in the field of biological science and
could also be applied to disease diagnosis and pharmaceu-
tical screening. Further developments in OMI for systems
biology are also proposed.
Keywords Optical molecular imaging . Fluorescent
protein . Quantum dots . Systems biology . Review
Abbreviations AFP: Aequorea fluorescent protein .
CFP: Cyan fluorescent protein . cpGFP: Circularly
permuted green fluorescent protein . cpYFP: Circularly
permuted yellow fluorescent protein . EGFP: Enhanced
green fluorescent protein . EYFP: Enhanced yellow
fluorescent protein . FCS: Fluorescence correlation
spectroscopy . FISH: Fluorescence in situ hybridization .
FLIM: Fluorescence lifetime imaging microscopy .
FP: Fluorescent protein . FRAP: Fluorescence recovery
after photobleaching . FRET: Fluorescence resonance
energy transfer . FSM: Fluorescent speckle microscopy .
GFP: Green fluorescent protein . LSCM: Laser scanning
confocal microscopy . MPLSM: Multiple-photon laser
scanning microscopy . OMI: Optical molecular imaging .
QDs: Quantum dots . RS: Raman spectroscopy .
ROI: Regions of interest . SBT: Spectral bleed-through .
WFM: Wide-field microscopy . YFP: Yellow fluorescent
protein
Introduction
Due to the rapid progress in the field of molecular biology
that has occurred over the last century, we have come to see
that life involves thousands of genes, proteins, metabolites,
etc. However, life is not invoked by simply collecting these
together; an integrated system formed from those compo-
nents is required. It is vital to understand biological
systems such as molecular networks, cells, tissues and even
the organism itself at the system level. This shift in
biological paradigm from reductionism to integration has
made the field of systems biology [1–5] a new challenge
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systematically understand biological systems can be
dated back to Wiener’s time [6], research into systems
biology represent the first attempts to achieve this based on
detailed knowledge of molecules. It promises to reveal the
relationships among elements of systems that may include
just a few proteins that together perform a defined task or
more complex molecular machines, cells and groups of
cells, with the goal of understanding their emergent
properties [3].
It is widely agreed that systems biology is a large
scientific field that relies greatly on collaborations between
disciplines such as the life sciences, information science,
system engineering and analytical technology. One of the
keys to successful research in this field is considered to be
work being done in analytical chemistry [7, 8] to develop
innovative analytical methods that meet the needs of
systems biology research. For example, capillary electro-
phoresis has been recognized as being the “gold standard”
in genomics for DNA sequencing. Similar “gold standard”
methods are available in transcriptomics (DNA micro-
array), proteomics (multidimensional separation coupling
with mass spectrometry) and metabolomics (microsepara-
tion coupled with mass spectrometry and nuclear magnetic
resonance). However, more of these methods are needed.
As well as revealing genes, proteins and metabolites from
those omic investigations, which relate to the basic
structures of systems, it is important to have methods
capable of monitoring their localizations, connections, and
in particular their dynamics over time under various
physiological or pathological conditions.
Optical molecular imaging (OMI) is a versatile tech-
nique that can be used to investigate the dynamics of
biological events in molecules, cells, tissues and organisms
in real time and in vivo (Fig. 1)[ 9–11]. Compared with
other imaging approaches like magnetic resonance imaging
and positron emission tomography etc., OMI exhibits the
great advantages of high temporal (picosecond) and spatial
(submicron) resolutions, high sensitivity (single-molecule
level) and minimal invasion, and shows high potential for
systems biology. This review highlights recent advances in
OMI, focusing especially on the development of fluores-
cent probes such as fluorescent proteins and semiconductor
nanocrystals (also referred to as quantum dots, QDs), OMI
instrumentation and approaches (techniques). The applica-
tion of OMI to studies of localization, conformations and
interactions of biomolecules in vivo are also highlighted. In
particular, this review describes the application of OMI for
tracing the dynamics of single molecules and whole-body
living organisms, which strongly suggest that OMI is an
informative systems biology method that may be used to
uncover biological events at different system levels. The
future development of OMI is also predicted.
Advances in fluorescent probes
Aequorea fluorescent protein (AFP)-derived mutants
Labeling of biomolecules with fluorescent probes or other
dyes has facilitated in vitro or in vivo studies of
biomolecular structures and dynamics, as well as their
interactions, which is critical if we are to understand the
biomolecular mechanisms of cellular function. However,
traditional methods of chemical labeling based on fluores-
cent dyes are often inadequate for biomolecular labeling,
repurification and reintroduction into cells by invasive
methods like microinjection. These limitations have
spawned efforts to noninvasively and site-specifically
label protein in living cells or tissues by using green
fluorescent protein (GFP) and its variants. The fluorescent
protein presents a relatively small size and a compact,
Fig. 1 Utilization of OMI in life science research. OMI can
investigate the dynamics of biological events in real time from
molecules (left), cells, tissues and organisms (right) digitally and
quantitatively. It can handle a wide range of intensities (about 12
orders of magnitude), times (femtoseconds to years) and spatial
dimensions (nanometers to centimeters), and it gives high spatial
and temporal resolution of the targeted cellular structures—better
than any other method
445single-domain structure, which allow it to fuse to other
targeted proteins with little or no interference in native
protein.
GFP was cloned from Aequorea victoria. Excitation of
the wild-type GFP by light with a wavelength of 398 nm
can induce the emission of bright green fluorescence,
peaking at 508 nm. Through continuous efforts to perform
protein mutation of GFP, scientists have developed various
kinds of AFP with different excitation and emission
wavelengths, enhanced brightness, and improved pH
resistance compared to the original wide-type, such as
enhanced GFP (EGFP), cyan fluorescent protein (CFP) and
yellow fluorescent protein (YFP) (Fig. 2a) [12]. The
original YFP exhibited several drawbacks when imaging in
vivo [13]. Later generations of YFP mutants, including
“Citrine” [14] and “Venus” [15], exhibit low pH (5.7)
resistance, halide insensitivity, greatly improved photo-
stability, brighter fluorescence, and faster maturation. The
original generation of CFP mutants also displayed several
spectroscopic disadvantages. By using similar methods to
YFP mutagenesis, a CFP mutant named “Cerulean” [16]
was obtained, with an improved quantum yield, a higher
extinction coefficient and a longer fluorescence lifetime.
Another new color GFP mutant, cyan-green fluorescent
protein (CGFP) [17], whose excitation and emission
wavelengths are intermediate between those of CFP and
EGFP,was also found by using this tactic. In addition, “PA-
GFP,” a GFP mutant, has 100 times greater fluorescence
than the original and remains stable for days [18]. These
fluorescent proteins were termed molecular or optical
highlighters, and represent perhaps the most promising
tools for investigating protein lifetimes, transport, turnover
rates and so on.
Other kinds of fluorescent protein
Long-wavelength fluorescence can provide greater tissue
penetration and better spectral separation from cellular
autofluorescence. Therefore, red fluorescent proteins
(RFP) are very useful in applications related to multicolor
protein-tracking and the construction of sensors. The first
RFP with a red emission wavelength was cloned from
Discosoma genus, named “DsRed” [19]. Its structure is
similar to GFP, but it is tetrameric. By using mutagenesis,
different derivations exhibiting several advantages have
been generated, such as the fluorescent timer of DsRed
which has fluorescence that changes from green to red over
time [20], the monomeric DsRed, named “mRFP1” [21]
(Fig. 2b), as well as DsRed2 [22], T1 [23], and mCherry
[24], which have chromophores that are brighter, more
soluble, and mature faster than the original generation.
Another orange-emitting fluorescent protein, which has
higher pH-resistance andis more effective for imaging, was
discovered in Fungia concinn [25]. In addition, “Kaede”
[26], which is cloned from Trachyphyllia geoffroyi, can
convert from green to red fluorescence and brightens
2,000-fold under UV illumination.
New rearrangement variants of fluorescent protein
In previous studies, fluorescent proteins were treated as an
indivisible entity, usually appended to the amino or
carboxyl terminus of the targeted protein. However, several
rearrangements of GFPs in which the amino and carboxyl
portions were interchanged and rejoined with a short spacer
still remained fluorescent (Fig. 2c). These circular
permutations exhibit several advantages, such as altered
pKa values, orientations of the chromophore with respect to
a fusion partner, and greater absorbance of the exciting
energy [27, 28].
Nongenetic fluorescent probes
However, there are some disadvantages of using FPs to
perform OMI of the whole-body. Given the available
wavelengths of excitation and emission and the power of
the FP, optical imaging with a depth of penetration of
approximately 1–2 mm limits their use to C. elegans,
Drosophila or surface structures in small animals. To solve
these problems, applying QDs (quantum dots) to OMI of
Fig. 2a–c Various FP mutants. a Introduction of the mutation of
Thr203His in GFP results in significantly red-shifted maximum
excitationandemissionwavelengths; thismutantisnamed YFP.bBy
using mutagenesis, the original tetrameric DsRed is reconstructed
into the monomeric DsRed variant. c Interchanging the amino and
carboxyl portions of GFP and rejoining them with a short spacer
generates cpGFP
446the whole-body could allow us to visualize biological
events in deeper tissues with better image quality.
Compared with conventional organic dyes and fluores-
cent proteins, semiconductor nanocrystals—quantum
dots—exhibit a narrow, tunable, symmetric emission
spectrum and better photochemical stability. Also, their
wavelengths of maximum excitation and emission shift to
shorter wavelengths with decreasing size [29, 30]. QDs
present several great advantages for whole-body OMI,
such as their very large molar extinction coefficients and
their very bright emission, which mean that the emission
can be visualized in big animals [31]; the ability to perform
simultaneous multiple color imaging of targets of interest
[32]; and long excited state lifetimes that provide a way to
separate the QD fluorescence from background fluores-
cence [33]. Because QDs are capped with a monolayer of
organic ligands and are hydrophobic, they cannot be used
for visualization in vivo. Goldman et al. [34] reported that
QDs capped with fusion proteins of a specific antibody,
protein G and leucine zipper adaptor protein could be used
to image the target protein in vivo (Fig. 3). Since then,
bioconjugated QDs have provided new approaches for the
ultrasensitive and multiple-color imaging of targeted
molecules in vivo. In addition, integrating QDs with
paramagnetic substances results in new multimodality
imaging probes that cuple the deep imaging capability of
magnetic resonance imaging with ultrasensitive OMI [35];
these would be very powerful probes if used in clinical
research. More recently, a new QD conjugate was found to
emit long waves in the absence of external excitation light
through bioluminous resonance energy transfer [36].
Compared with existing quantum dots, self-luminous
quantum dots provide great sensitivity when imaging
small animals, giving high signal-to-noise ratios.
OMI techniques
General imaging microscopy
Laser scanning confocal microscopy (LSCM) (Fig. 4a) and
wide-field microscopy (WFM) are the tools most widely
used for in vivo OMI. The major difference between them
is that LSCM only collects the fluorescence emission of in-
focus light, whereas WFM collects all signals, including
out-of-focus light [37]. LSCM can produce superior
images of multiple-cell samples, with photobleaching.
However, LSCM cannot perform multiple-color imaging
because it only observes in-focus light [38]. WFM is among
the most sensitive of all such methods, permits minimal
exposure of the sample, uniform illumination, an unlimited
choice of excitation wavelengths, and is relatively simple
[37]. One of the disadvantages of WFM is that disturbances
areseeninobservations ofthickerspecimens,wheretheout-
of-focus signals become substantial [38].
Furthermore, multiple-photon laser scanning microsco-
py (MPLSM) has also been used in OMI [39]. The
principle of MPLSM is that pulsed long excitation
wavelength light, such as that provided by an infrared
(IR) laser beam, is used to excite a molecule at the focal
plane by multiple photons, causing fluorescence (Fig. 4b).
The advantages of MPLSM are high tissue penetration
ability (>30 μm), low photobleaching or photodamage, and
a high signal/noise ratio (due to low autofluorescence) [40].
Second-harmonic imaging microscopy (SHIM)
SHIM is based on a nonlinear optical effect called second
harmonic generation (SHG), commonly called frequency
doubling. This phenomenon requires that intense laser light
passes through a highly polarizable material with noncen-
trosymmetric molecular organization [41]. Biological
macromolecules often assemble into large, ordered noncen-
trosymmetric structures and have highly polarizability.
Therefore, high-resolution SHIM imaging can visualize
livingcellsortissues.Thismethodprovidesseveralbenefits:
the targeted molecules are not excited, photobleaching does
not occur, and it can detect information related to pathology.
In addition, a combination of SHIM and MPLSM could
make a powerful optical imaging technique.
Optical coherence tomography (OCT)
The principle of OCT imaging is analogous to that of
ultrasound B-mode imaging, except that OCT uses light
rather than acoustic waves [42]. OCT can provide cross-
sectional imaging of structures below the tissue surface,
analogous to histopathology. By using a state-of-the-art
laser as the light source, ultrahigh-resolution imaging with
axial resolutions as fine as 1–2 μm can be achieved [43].
Fig. 3 Method of conjugating
QDs to target proteins. The pG-
zb acts as a molecular adaptor,
connecting the QDs with the
target protein through interac-
tions of its protein G portion
with a specific antibody as well
as interactions of its positively
charged tail with QDs capped
with a negatively charged dihy-
drolipoic acid surface
447However, the penetration depth of the technique in most
tissues is limited to approximately 2–3m m[ 44]. Several
features of OCT imaging make it well-suited to imaging-
based diagnostics and surgical guidance, such as its high
resolution, its ability to quantitatively assess, and its ability
to image some tissue functions.
Fluorescent molecular imaging approaches
Fluorescence resonance energy transfer (FRET)
FRET is a quantum mechanical phenomenon that occurs
between a fluorescence donor and a fluorescence acceptor
with a favorable dipole–dipole orientation that are in
molecular proximity to each other, provided the emission
spectrum of the donor overlaps the excitation spectrum of
the acceptor (Fig. 4c) [45]. Therefore, imaging based on
FRET can determine the proximity (within the nanometer
range) between labeled biomolecules in living cells [46,
47]. FRET-based microscopy includes intensity-based
detection methods and fluorescence decay kinetics-based
detection methods [46]. Similar to general fluorescence
imaging microscopy, FRET also suffers from various
drawbacks, like autofluorescence, detector noise, optical
noise and photobleaching. In addition, spectral bleed-
through (SBT), or cross-talk, is a major problem in FRET
[48]. FRET is currently widely used in studies of protein
colocalization, conformational changes, protein interac-
tions and signal transduction [47, 49].
Fluorescence recovery after photobleaching (FRAP)
FRAP involves observing the rate of recovery of fluores-
cence resulting from the movement of a fluorescent marker
into an area which contains the same marker that has been
rendered nonfluorescent via an intense photobleaching
pulse of laser light (Fig. 4d). FRAP has proved to be a
powerful method for measuring the mobilities of target
Fig. 4a–f Fluorescent OMI approaches. a LSCM only collects in-
focus emitted light. b The principle of multiple photon excitation is
based on the use of pulsed long excitation wavelengths to excite
fluorescence. c FRET occurs between a donor and an acceptor that
are in molecular proximity if the emission spectrum of the donor
overlaps the excitation spectrum of the acceptor. d FRAP can reveal
the mobility of FP-labeling proteins. These images illustrate the
change in fluorescence of cells expressed with YFP-hGR before and
after photobleaching. Reproduced from [51] with permission.
e FLIM can measure the time-dependent emission intensity. The
histogram represents the fluorescence lifetime distributions for the
donor in the presence of interactions (red) or not (yellow).
Reproduced from [57] with permission. f FCS can monitor the
fluorescence signals emitted from the ROI. The cross-correlation
curve (black) indicates a higher level of dimer or oligomer formation
in the R1- and R5-expressing cells. Reproduced from [59] with
permission
448molecules in various membranes, cytoplasms and nuclei
[50]. For example, the mobility of the hormone receptor in
the nucleus of a living cell [51], the mobility in subcellular
compartments and the dynamics of vesicles inside the
synapses of cultured hippocampal neurons [52] have been
studied using this approach.
Fluorescence lifetime imaging microscopy (FLIM)
FLIM is a technique by which the mean fluorescence
lifetime of a chromophore is measured at each spatially
resolvable element of a microscope image [53]. The
fluorescence lifetime is an inherent property of a chromo-
phore that is sensitive to environmental and physical
processes. Therefore, FLIM can detect interesting physical
processes that can influence the excited state of a probe in
vivo [54]. In addition, the mean lifetime of a donor is
shifted to shorter lifetimes in the presence of an acceptor in
FRET (Fig. 4e), so FLIM can detect changes in FRET [55],
although this may not be valid in complex cellular systems
that consist of several different lifetime components [56].
For example, using a FRET–FLIM method, the regulation
of the activity of receptor protein tyrosine kinase (RPTK)
through its dimerization was demonstrated in living cells
[57]. The main drawbacks of FLIM are that it has relatively
low sensitivity and requires expensive instrumentation.
Fluorescence correlation spectroscopy (FCS)
FCS is an approach that has emerged only recently. It is a
high-sensitivity photon-counting technique that permits
fluctuations in the fluorescence signal due to changes in
the fluorescence quantum yield to be measured (Fig. 4f)
[58]. Therefore, FCS can directly measure the mobilities
of biomolecules, and it can monitor the average associa-
tion and dissociation of target labeled with fluorescence
probe—which vary with interaction kinetics, complex
composition and complex size—in vivo without photo-
bleaching. For example, FCS can be used to detect the
clustering of somatostatin receptors [59] and the binding
affinities of glucocorticoids (GC) in different subcellular
compartments [60].
Applications of OMI
OMI for biomolecules
Originally, OMI of biomolecule function was performed on
dead fixed cells or tissue sections in vitro. The first
application of fluorescent detection in situ emerged in
1980, when RNA that was directly labeled with fluoro-
phore was used as a probe for specific DNA sequences
[61]. However, this method is not sensitive enough.
Another indirect detection method allows signal to be
significantly increased by binding secondary reporter to the
hybridization probes that bind to targeted DNA [62] and
mRNA [63]. Recently, Santangelo et al. [64] indicated that
coinjection of two beacons based on FRETcould be used to
map the localization of a specific hybridization in living
cells. Another application of FISH is immunocytochemis-
try (IC), which is used to detect target protein in specimens
in vitro as antigen by means of antibodies labeled with
fluorescence probe [65]. The technique of FISH is still
being developed, with more specific fine-tuning of sensi-
tivity and multiplicity necessary, after which its applica-
tions should gradually move from being in vitro to in
vivo [66].
In addition, Fourier transform infrared (FT–IR) spec-
troscopy allows the simultaneous detection of nearly all
organic molecules in a single spectrum and hence is ideally
suited for the investigation of complex metabolic path-
ways. However, this advantage is only useful when
powerful mathematical methods are available for the
analysis of the highly complex spectra produced. Glyco-
lytic intermediates In yeast extract were identified with
FT–IR spectroscopy. The results were in good agreement
with known phase relationships in oscillatory glycolysis
[67]. In another experiment, glycogen, protein, lipid and
nucleic acid concentrations were monitored in fish liver
[68] using this method.
Single-molecule OMI is a very young field that holds
great promise. It is not a technique, but a way of thinking
that can allow us to detect individual molecular interac-
tions, protein dynamics and signaling transduction path-
ways in living cells, which is difficult and sometimes
impossible to achieve using conventional techniques [46].
For example, Sonnleitner et al. observed that the voltage-
gated ion channel does not directly open or close under the
conditions of single-molecular interaction using this
approach [69]. Karymov et al. reported a method that
could be used to directly follow junction branch migration
in the holiday junction at the single-molecule level, and
they detected that branch migration was a stepwise random
process where the overall kinetics were dependent on the
Mg
2+ concentration [70].
Using OMI to monitor physiological processes
in living cells
Monitoring gene expression and RNA localization
The fusion of gene promoter and fluorescent protein cDNA
can be used to noninvasively analyze the expression pattern
of a target gene, which is a very common approach used to
study gene expression in vivo and is widely used in life
science research. To minimize the accumulation of the
background fluorescence that is generated by leaky,
undegraded level (i.e. from previously expressed fluores-
cent protein that has not yet degraded), several chimeric
EGFPs with shorter fluorescence half-lives were con-
structed by fusing protein [71, 72]. However, this approach
leads to lower sensitivity, and cannot reveal low levels of
expression. To overcome these drawbacks, a new approach
that is similar to the amplification of an enzymatic reporter
449was applied, which was then used in “enhancer-trap”
strategies [73, 74]. The principle behind this is that the
fluorescence of FP, revealing targeted gene expression in
different tissues, is magnified through a transcript factor,
which allows weak signals to be seen.
In addition, DNA and RNA sequences and other
molecules could be visualized indirectly by labeling their
binding proteins with FP in vivo. For example, by using
RNA binding protein MS2 labeled with GFP, the mobility
of targeted RNA could be visualized in vivo [75]. In
another study, a similar method was used to observe gene
expression correlated with a change in chromatin structure
under the progress of transcription in real time [76].
Compared with FISH in vivo, the disadvantage of this
method is the introduction of a protein complex of
considerable size.
Monitoring protein and subcellular organelle
dynamics
FP can also be used to monitor the behavior of the targeted
protein, such as its appearance, degradation, localization,
translocation and interaction in vivo. For example, by using
a fusion protein of GR and FP, the dynamics of the
exchange of GR with its binding sequence array can be
monitored [77]. In addition, visualization of the dynamics
of the GFP-GR fusion protein in vivo in more physiolog-
ical conditions was achieved by using GFP-GR knock-in
mice [78]. Another interesting application involves identi-
fying the localization of an unknown protein on a large
scale, a method termed the “protein trap,” in which the
imaging of cells containing the fusion protein of FP and a
cDNA library was used to screen for target protein at the
localization of interest [79].
Fusion protein that targets a given subcellular organelle
is often used to study the dynamics of subcellular
organelles. For example, Shaw et al. [80] revealed the
dynamics of migration across the cell cortex of individual
cortical microtubules in Arabidopsis by using tubulin fused
to FP. In a similar study, this method was used to measure
the rates of tubulin polymer growth, shortening and
transition [81]. Furthermore, new subcellular structures
can also be discovered by visualizing fusion FP, such as the
novel discrete area in the nucleus, in which phytochrome
species were induced to accumulated by light [82].
Monitoring general protein–protein interactions
Detecting the proximity of two biomolecules based on
FRET is an approach widely used to observe protein
interactions in real time in vivo. Most commonly, CFP and
YFP are respectively fused to each of their putative
interaction proteins, which are coexpressed in one living
cell so that FRET between two fused FPs of interaction can
be detected (Fig. 5a). A variety of protein interactions in
different cells have been successfully visualized so far
using intermolecular FRET, suchas the interaction between
phytochrome B and cryptochrome 2 [83], the rearrange-
ment of G-protein subunits [84], and the oligomeric states
of the ligands B7-1 and B7-2 [85]. Protein–protein
interactions can also be imaged via protein complementa-
tion assays. The putative interaction proteins are respec-
tively fused to two complementary fragments of one
fluorescent protein, and then interaction of the proteins can
reinvoke the fluorescence [46, 86], in a technique which is
analogous to yeast two-hybrid assays (Fig. 6a). Using this
method, Hu et al. simultaneously visualized several
interactions among bZIP and Rel family transcription
factors in one cell [87, 88].
Monitoring protease and kinase activity
The first reporter of proteolysis consists of BFP and GFP
fusing together with a protease-sensitive linker, which
exhibits the FRET phenomenon.Proteolysis can disrupt the
FRET by separating the donor and acceptor fluorescent
proteins [89]. In recent studies, fusion proteins of CFP,
Fig. 5a–d General designs of FRET-based fluorescent probes. a An
intermolecular probe consists of two interacting proteins that are
labeled with CFP and YFP, respectively, which interact and result in
FRET. b An intramolecular probe consists of CFP and YFP fused
together with a cleavable linker or protein, which can be cleaved by
proteolysis and disrupt FRET. c An intramolecular probe consists of
sandwiching two domains between CFP and YFP, which can
interact after phosphorylation or binding to calcium, resulting in a
change in FRET. d An intramolecular probe consists of CFP, YFP
and a protein/domain, which permits conformational change by
binding to another biomolecule, leading to a change in FRET
450YFP and a specific recognition sequence were used to
measure the different caspase proteolytic activities during
different apoptosis pathways (Fig. 5b) [90–92]. In another
study, YFP-Bid-CFP fusion protein was used to visualize
the activation of Bid protein by proteolytic cleavage, and
translocation of the cleaved Bid to mitochondria was
observed directly [93].
Reporters for the activity of tyrosine kinases and serine/
threonine kinases have been made by sandwiching a
substrate peptide for the kinase of interest and a
phosphoaminoacid-binding domain, such as Src-homolo-
gy-2 (SH2) or 14-3-3 protein, between two FPs (Fig. 5c).
Phosphorylation of the substrate peptide induces the
formation of an intramolecular complex with the phospho-
aminoacid-binding domain, which leads to a change in the
FRET. Meanwhile, these indicators also report the opposite
phosphatase activity. This generic concept has so far been
adapted to create probes for the phosphorylation of the
kinase of interest in different signal transduction pathways,
including phosphorylation of protein kinase A (PKA) [94],
activation of serine/threonine kinase Akt [95], and activa-
tion of Src kinase on the cell membrane [96].
Monitoring changes in calcium
Genetically encoded fluorescent indicators for calcium
without cofactors that can target to specific intracellular
locations were first constructed by Miyawaki et al. [97].
This indicator was termed “cameleon.” The cameleon
consists of the tandem fusion of CFP, calmodulin, the
calmodulin-binding peptide M13 and YFP. Binding of
Ca
2+ allows calmodulin to wrap around the M13 domain,
which increases the FRET between flanking FPs (Fig. 5c).
Replacing YFP with cpYFP [28], Venus [98] or EYFP [99]
led to a new generation of cameleon that exhibited better
spatial and temporal resolution as well as better environ-
mental resistance. In order to measure high concentrations
of Ca
2+, the CaM–M13 interface of cameleon was re-
engineered to reduce its affinity to Ca
2+, which improved
the imaging of Ca
2+ in the endoplasmic reticulum [100].
Other indicators for calcium that are not based on FRET
have also been reported. cpGFP or cpYFP can tolerate the
insertion of another entire protein, and conformational
change of the fusion cpFP can change its fluorescence.
Therefore, the insertion of calmodulin into cpYFP (called
“camgaroos”) (Fig. 6b) [14, 27] and the tandem fusion
protein of M13, cpGFP and calmodulin (termed
“G-CaMP”) (Fig. 6c) [101] have both been used as
calcium indicators because a conformational change occurs
in the fusion cpFPs upon calcium binding.
Monitoring changes in cyclic nucleotides
The first fluorescent sensor of cAMP consists of cAMP-
dependent protein kinase (PKA) in which the catalytic
subunit and the regulatory subunit are labeled with a
fluorescein and a rhodamine, respectively. Binding of
cAMP to the labeled regulatory subunit leads to the
dissociation of the labeled catalytic subunit, which disrupts
the FRET between the two fluorescent dyes [102]. Later,
this system was developed into a genetic cAMP indicator
with BFP and GFP replacing the fluorescent dyes [103].
The most recent cAMP indicator was constructed by
sandwiching a full length Epac1 between CFP and YFP
(Fig. 5d) [104].
A genetically encoded indicator for another cyclic
nucleotide, cGMP, has been reported by Sato et al. [105].
Fig. 6a–d Single FP-based fluorescent probes. a The probe consists
of the fusion of two interacting proteins to two complementary
fragments of one FP, respectively, which can interact and reinvoke
the fluorescence. b Insertion of a conformationlly responsive
domain/protein into cpYFP can lead to a change of fluorescence
when its conformation is changed. c The probe consists of the fusion
of two interacting proteins/domains to the amino and carboxyl
termini of cpGFP, which can interact and change the cpGFP
fluorescence. d By using mutagenesis, AFP can be engineered to be
directly sensitive to a small molecule, such as Cl
−,H
+
451This indicator consists of a tandem fusion of BFP,
nondimerizing mutants of cGMP-dependent protein kinase
Iα (PKG Iα) and GFP. An increase in FRET between the
two FPs can be detected upon the cGMP-induced
conformational change of PKG Iα. Another sensor, termed
“cygnet-1” [106], was constructed to have high selectivity
for cGMP over cAMP. Here, the truncation of PKG Iα
consisted of residues 1–77 rather than 1–47 reported in a
previous study [105], and it exhibited decreased FRET
fluorescence upon the binding of cGMP.
Monitoring changes in transmembrane voltage
Measuring electrical activity in living cells with high
spatial and temporal resolution is a fundamental problem in
studies of excited cell information processing. To address
this problem, Siegel and Isacoff [107] first constructed a
novel fluorescent probe that could be used to measure
transmembrane voltage in vivo, termed the fluorescent
shaker or “FlaSh”, in which the modified GFP was inserted
into a voltage-sensitive K
+ channel so that voltage-
dependent rearrangements in the K
+ channel fusion protein
could induce changes in the GFP fluorescence. A similar
voltage sensor was generated by inserting GFP into another
channel, the rat μI skeletal muscle voltage-gated Na
+
channel, and was named “SPARC” [108]. In other studies,
Sakai et al. [109] developed a new voltage-sensitive
indicator based on FRET, in which changes in membrane
voltage can lead to changes in FRET.
Monitoring changes in pH in living cells
The chromophore of a FP is surrounded by a hydrogen-
bonding network within the β-barrel, which means that the
FP is pH-sensitive because of direct interactions between its
hydrogen-bonding network and external protons [12]. The
majority of GFP, YFP and their circularly permuted con-
structions described in previous parts of this review exhibit
s e n s i t i v i t yt oa c i d( F i g .6d), whereas the original AFP—
Renilla reniformis GFP—and DsRed are insensitive to acid.
Therefore, acid-sensitive variants can serve as ideal donors
in pH indicators based on FRET, and DsRed is the most
desirable acceptor [110]. Another pH sensor has been
generated by using a new group of pH-sensitive GFP
variants, termed “deGFPs,” which exhibit rapid changes in
emission from green to blue as the pH decreases, and these
are suitable for ratiometric measurements in vivo [111, 112].
Monitoring signal transduction from cell to cell
Scientists have also monitored intercellular changes in
biomolecules and physiological events, which have been
visualized in single cells in real time in a cell population.
For example, Bedner et al. monitored the intercellular
permeability to cAMP of six different gap junction
channels by using sensors that are highly sensitive to
cAMP concentration [113]. The change in calcium con-
centration from cell to cell was also monitored via calcium
dyes [114]. In addition to these biomicromolecules, the
propagation of intercellular apoptotic or survival events in
monolayer cells mediated by the gap junction channel were
also studied through OMI [115].
Using OMI to investigate tissue structure and function
It has recently been shown that SHIM can be used to
directly detect several structural protein arrays in tissues,
such as collagen arrays in mouse [116], neurons and
muscular structures of the pharynx in C. elegans [117]
without the need for fluorescent labeling. SHIM also
readily retrieves more detailed molecular information than
that obtained through the application of fluorescent
labeling. Therefore, SHIM can be used to study or diagnose
several diseases that are related to the assembly polarity of
microtubule complexes in native brain tissue [118]. In
addition, SHIM has proven to be crucial to neuroscience
investigations in thick tissue preparations. For example, the
fast neuronal membrane potential transient in mammalian
brain slices labeled with FM4-64 dye was investigated by
this method [119]. By labeling with another dye, the action
potential was recorded with high temporal and spatial
resolution on soma and neurite membranes [120].
OCT also has the ability to perform in situ, real-time
imaging of tissue pathology, and it can be used to guide
excisional biopsy in order to reduce false negatives caused
by sampling errors. In particular, OCT enables the internal
architectural morphology of the retina to be visualized
noninvasively, and it can be used to diagnose and monitor
retinal diseases, which cannot be achieved through any
other methods [121]. The development of high-speed OCT
imaging combined with small fiber-optic probes has
enabled in vivo endoscopic imaging, such as the visuali-
zation of the oral cavity [122], the larynx and the bladder
[123]. In addition, OCTcan perform functional imaging of
tissues, such as brain activity [124], inflammatory/neo-
plastic morphologic changes [125]. Raman spectroscopy
(RS) is another powerful diagnostic tool that enables tissue
identification and classification, as demonstrated by
measurements of the brain tissue of a six-month-old pig
by fiber-optic probes [126] and analysis of the molecular
composition of human bronchial tissue structures [127].
Also, a combination of confocal RS and LSCM has been
employed to obtain detailed information about the sub-
surface structures in the skin with high spatial resolution in
a completely noninvasive manner [128].
OMI of organisms
Employing fluorescent protein
When performing whole-body OMI of organisms, the
utilization of genetically encoded fluorescence probes has
enabled scientists to decipher spatial and temporal changes
452in biological events inside complex organisms [129]. Over
the past few decades, FPs have been used to generate
various fluorescent probes that have been used to image
physiological and biochemical events in the monolayer
cells. Extracting information from whole-body imaging is
more relevant to real physiological conditions, but up to
now, only a few fluorescent indicators have been used in
complex organisms to visualize physiological activity in
vivo.
To study the feeding behavior of C. elegans, Kerr et al.
[130] introduced a calcium indicator based on cameleon to
C. elegans, which allowed them to measure the Ca
2+
signals evoked in pharyngeal muscles and individual neu-
rons under the stimulation of feeding in vivo (Fig. 7a,b).
Similar visualization of cameleon localized in other tissues
was used to study the functions of serotonin and G proteins
[131], the role of G proteins in signal transduction [132],
and the ASH neuron response [133]i nC. elegans. The
Fig. 7a–k Whole-body OMI using FPs and QDs. Imaging of Ca
2+
signals in pharyngeal muscles under the conditions of noncontrac-
tion (a) and contraction (b)( red color indicates higher calcium) in
transgenic C. elegans expressing cameleon. Reproduced from [130]
with permission. c–f Ca
2+ signals evoked by different odors in
Drosophila brain expressing G-CaMP. Reproduced from [135] with
permission. Imaging of a three-day-old transgenic fish (g) carrying
the cameleon and its RB neurons (h) by confocal optical section,
and the change in the fluorescence ratio (i) (representing the calcium
concentration) in an RB neuron under electrical stimulation of the
skin. Reproduced from [136] with permission. j Simultaneous
multicolor imaging in a mouse injected with QD-encoded micro-
beads; k QD imaging of a prostate tumor in the mouse. Reproduced
from [33] with permission
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454spatial and temporal representation of odorant-evoked Ca
2+
signals in the Drosophila brain was explored using
cameleon [134] and G-CaMP (Fig. 7c–f) [135]. Calcium
imaging was also used in other animals, such as zebrafish
(Fig. 7g–i) [136] and mouse [137, 138]. In addition, an
indicator with pH sensitivity was used to visualize spatial
patterns of defined neuronal activity in the mouse [139].
More recently, the proteolytic activity of calpain was
visualized by introducing fluorescent indicator into living
mouse muscle, which gave the first 3-D imaging of FRET
in vivo [140].
Employing QDs
Due to several advantages of QDs over FP, QDs have been
used to image large animals in vivo, which holds great
promise for clinical applications, especially in the imaging
of tumors. Akerman et al. [141] report the application of
QDs coated with specific targeting peptides to the imaging
of different tissues in tumor in vitro, but this QD probe
cannot be detected in living animals. Gao et al. [33] report
on a new class of multifunctional QDs that were encap-
sulated with an ABC triblock copolymer and then linked
with a tumor-targeting antibody. Using subcutaneous
injection or systemic injection of these QDs into the
mouse, simultaneous multicolor fluorescence imaging of
the prostate tumor with efficient background removal and
precise delineation of weak spectral signatures based on
wavelength resolution was achieved (Fig. 7j,k). More
recent research showed that the utilization of QDs in
combination with GFP labeling can differentiate tumor
vessels from both perivascular cells and the matrix, and
QDs linked to bone marrow-derived precursor cells can
visualize tumor vasculature [142]. These OMI techniques,
as well as their applications at different biological levels,
are summarized in Table 1.
Future development
As described above, OMI is a feasible analytical technique
for monitoring the dynamics of biological events in vivo
and in real time anywhere from single-molecule to whole-
body level, which makes it well-suited to systems biology
measurements. Its noninvasive, ultrasensitive, high-reso-
lution and real time nature has resulted in the widespread
use of OMI. However, its disadvantages are also very
apparent, such as its high cost, its low throughput, and its
limited detectable depth, which is a particular hindrance in
whole-body analysis. It should be pointed out that OMI is
still far from fulfilling all of the requirements of systems
biology (as concluded in our previous paper [8])—in terms
of sensitivity, selectivity or specificity, linear range of
quantitation, throughput, robustness, flexibility and cost—
that are definitely required in genomics, transcriptomics,
proteomics, and metabolomic profiling and dynamics,
although it it clear that OMI is a promising method for
these types of bioanalysis.
In the near future, several routes to improving OMI for
systems biology need to be followed. Firstly, it is crucial to
develop better molecular probes for OMI; in other words
probes that have improved biocompatibilities and high
quantum yields, are easy-to-tag, display multiple colors
and have better penetration capabilities. The importance of
the molecular probe to OMI cannot be overstressed.
Current endeavors in QD development are heading in a
good direction but this field is still in its infancy [143].
However, this doesn’t mean that the development of small
organic dyestuffs and biogenetic FP is less important: on
the contrary, applications of these two kinds of molecular
probes will still constitute most OMI studies [144].
Secondly, the integration of several modalities or ap-
proaches should be emphasized, since it makes OMI much
more informative. Thirdly, efforts to improve OMI instru-
mentation are also important, since they will result in better
time and space resolution and better sensitivity. For
example, the 4Pi technique has improved the spatial
resolution of OMI down to the mid-nanometer level, which
is over the diffraction limit. The rapid progress currently
being achieved in nanotechnology and nano/microelec-
tromechanical systems looks set to lead to the manufacture
of low-cost and high-efficiency OMI instruments [145].
Finally, the application of OMI to the life sciences is
important; it is the reason behind the development of OMI.
In particular, the application of OMI to systematic
measurements of biological systems will be of great
interest, which is also the aim of systems biology.
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